Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July 2007 - June 2008 ) © Copyright NHSBSA 2008.

Slides:



Advertisements
Similar presentations
Proton Pump Inhibitors
Advertisements

GI Drugs PHC 5409B Dr. T.C. Peterson.
Antacids L. Scheffler 1.
INDIGESTION (DYSPEPSIA) AND HEARTBURN (ACID REFLUX)
% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England.
GASTRO-INTESTINAL DRUGS
Drugs Used in Gastrointestinal System Prof. : Abdulqader A. ALHAIDER.
DYSPEPSIA Dr.Vishal Rathore. Dyspepsia popularly known as indigestion meaning hard or difficult digestion, is a medical condition characterized by chronic.
Drugs Affecting Gastrointestinal Function OUTLINE  Peptic Ulcer  Digestion  Vomiting  Diarrhea  Bile  Review-Questions.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Drugs for Peptic Ulcer Disease Chapter 73.
Gastroenterology in General Practice. Gastroenterology Dyspepsia Ulcer disease Non-ulcer dyspepsia Helicobacter pylori Altered Bowel Habit Constipation.
A Nationwide Population-Based Cohort Study Shows Reduced Hospitalization for Peptic Ulcer Disease Associated With H pylori Eradication and Proton Pump.
Peptic Ulcer Disease Dr. Wael H. Mansy, MD Assistant Professor
Diagnostic Evaluation Radiographic barium study –Less sensitive in small ulcers
OPPORTUNITIES FOR RESEARCH IN PRIMARY CARE Jen Dumbleton Clinical Trial Manager University of Nottingham
Pharm. Ibrahim Bussati. * AlHO MgHO * simeticone.
Peptic Ulcer Disease. Peptic ulcer  refers to erosion of the mucosa lining any portion of the G.I. tract.  It is defined as : A circumscribed ulceration.
Trends in Usage of Non-Opioid Analgesics in General Practice in England © Copyright NHSBSA 2008.
Treatment of Arthritis Dr. Kaukab Azim. Medicinal Treatment for Arthritis 1. Pain Relief: The most common medication used for acute pain relief.
Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009.
Pharmacology B Lin, I-Yao. A 43y/o male CEO of a multinational company experienced severe burning pain one and a half hour after a sumptuous lunch. This.
Chapter 24 Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease.
Trends in Spending on Selective Beta 2 Agonists in General Practice in England.
Trends in Prescribing of Selected Alpha-Blockers in General Practice in England © Copyright NHSBSA 2008.
Block 1 Pharm Cameron Blair & Josh Solomon. Learning outcomes Mechanisms of action, S/E & examples of: O Drugs that protect the stomach O Anti-diarrhoeal.
Peptic Ulcer Disease Dr. Wael H. Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Trends in Prescribing of Sodium Chloride Irrigation Solutions in General Practice in England © Copyright NHSBSA 2008.
Gastrointestinal Pharmacology
Update of TARGET ( T reatment a nd R elief of G astroint e s t inal disorder) DR NORITA YASMIN MORNING READ 19/9/13 1.
% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England © Copyright NHSBSA 2009.
An Evaluation of Clinical Pharmacists Impact on Drug Utilization of Traditional NSAIDS and Selective COX-II Inhibitors S. Scott Sutton, Pharm.D. Associate.
Pharmacology of drugs affecting GIT
Trends in Spending on Selective Beta 2 Agonists in General Practice in England © Copyright NHSBSA 2009.
PHARMACOTHERAPY OF ULCER DISEASE This study material is recommended specifically for practical courses from Pharmacology II for students of general medicine.
REPENTURN July 5, 2015 REPENTURN REPENTURN REPENTURN.
L. Scheffler with additional material by A J Hennigan!
Antacids 1.
Drugs for Gastrointestinal and Related Diseases
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2.
Copyright © 2000 American Medical Association. All rights reserved.
Comparative success of therapy with proton pump inhibitors and H2 receptor antagonists. Data show the effects of a proton pump inhibitor (given once daily)
Copyright © 2011 American Medical Association. All rights reserved.
M.A.M. Rogers, D.M. Aronoff  Clinical Microbiology and Infection 
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society.
Guidelines for the evaluation and management of a patient who presents with dyspeptic or ulcer-like symptoms. (COX-2, cyclooxygenase-2; GERD, gastroesophageal.
Medical management of inflammatory bowel disease
Nonsteroidal Anti-inflammatory Drugs, Proton Pump Inhibitors, and Gastrointestinal Injury: Contrasting Interactions in the Stomach and Small Intestine 
An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori  Sarah Gurney, MSN, FNP, Laura Carvalho, MSN, FNP, Carrie Gonzalez, MSN,
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole  Gerald Holtmann*,
Nonsteroidal Anti-inflammatory Drugs, Proton Pump Inhibitors, and Gastrointestinal Injury: Contrasting Interactions in the Stomach and Small Intestine 
An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori  Sarah Gurney, MSN, FNP, Laura Carvalho, MSN, FNP, Carrie Gonzalez, MSN,
Chapter 36: Drugs for Peptic Ulcer Disease
Proton Pump Inhibitors for Gastroduodenal Damage Related to Nonsteroidal Anti- inflammatory Drugs or Aspirin: Twelve Important Questions for Clinical Practice 
داروهای کاهنده حرکت و ترشح
Analgesics Review 8 December :38 AM.
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2.
A Nationwide Population-Based Cohort Study Shows Reduced Hospitalization for Peptic Ulcer Disease Associated With H pylori Eradication and Proton Pump.
An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori  Sarah Gurney, MSN, FNP, Laura Carvalho, MSN, FNP, Carrie Gonzalez, MSN,
M.A.M. Rogers, D.M. Aronoff  Clinical Microbiology and Infection 
R.S. Vela Vásquez, R. Peláez Romero  British Journal of Anaesthesia 
Volume 84, Issue 1, Pages (July 2013)
Effect of antioxidants on the immune response of Helicobacter pylori
Volume 133, Issue 3, Pages (September 2007)
Volume 154, Issue 4, Pages (March 2018)
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole  Gerald Holtmann*,
The Toronto Helicobacter pylori Consensus in Context
Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis 
Hugh Taggart, MD, Michael A
Rebecca D. Chason, Joan S. Reisch, PhD, Don C. Rockey, MD 
Presentation transcript:

Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July June 2008 ) © Copyright NHSBSA 2008

Pie Chart Showing the Breakdown of Gastro-intestinal Spending in General Practice in England (July June 2008) © Copyright NHSBSA 2008

Trends in Prescribing of Antacids and simeticone in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Antacids and simeticone in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Compound Alginate Preparations in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Compound Alginate Preparations in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Ulcer-healing drugs in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Ulcer-healing drugs in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of and Spending on Helicobacter pylori tests in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of H2-receptor antagonists in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on H2-receptor antagonists in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Proton Pump Inhibitors in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Proton Pump Inhibitors in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Lansoprazole by Strength in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Omeprazole by Strength in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Aminosalicylates for Inflammatory Bowel Disease in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Aminosalicylates for Inflammatory Bowel Disease in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Corticosteroids for Inflammatory Bowel Disease in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Corticosteroids for Inflammatory Bowel Disease in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Laxatives in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Laxatives in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Lactulose Solution in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Aspirin (BNF 2.9 & 4.7.1) in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Aspirin (BNF 2.9 & 4.7.1) in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of NSAIDs in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on NSAIDs in General Practice in England © Copyright NHSBSA 2008

Trends in Prescribing of Cyclo-oxygenase-2 Selective Inhibitors in General Practice in England © Copyright NHSBSA 2008

Trends in Spending on Cyclo-oxygenase-2 Selective Inhibitors in General Practice in England © Copyright NHSBSA 2008